Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • tinguzman
    Member
    • Aug 2014
    • 13

    #1

    change default FDR on edgeR

    Hi,

    Could anyone please tell me how to change the FDR from default (0.05) to 0.0001 in edgeR?

    et <- exactTest(y, pair=c("1","2"))
    out.adjusted <- topTags(et, n=Inf, adjust.method="BH")
    out.adjusted.keep <- out$table$FDR <= 0.0001

    I'm not sure if i understand this correctly, topTags function with adjust.method will adjust the pvalues from et, using BH/FDR set at 5%, which is the default. then, the FDR column of the output file are the adjusted p.values, on this case retaining only those with <=0.0001 values.

    appreciate your help!
  • dariober
    Senior Member
    • May 2010
    • 311

    #2
    The BH/FDR method corrects your pvalues according to their number and distribution, there is no threshold to set there. Maybe the 5% you refer to is the usual threshold people use to filter results. So, if you want to keep genes with FDR < 0.0001 it seems to me that your code is fine (by the way <0.0001 is very stringent, if you have many genes maybe consider shareholding also on logFC and logCPM).

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 08-13-2026, 12:22 PM
    0 responses
    29 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-11-2026, 10:35 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-06-2026, 07:41 AM
    0 responses
    38 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-03-2026, 10:13 AM
    0 responses
    51 views
    0 reactions
    Last Post SEQadmin2  
    Working...